Our data showed that directly silencing of IL1 signaling molecules such as IL1R1 and IL1RAP significantly reduced the survival and growth of KSHV+ tumor cells, indicating targeting IL1 signaling may represent a promising strategy for treatment of KSHV-related malignancies. The gene discussed is IL1A; the disease is neoplasm.